Mylan (NASDAQ: MYL) reported Q4 EPS of $1.22, $0.05 worse than the analyst estimate of $1.27. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.7 billion.

GUIDANCE:

Mylan sees FY2016 EPS of $4.85-$5.15, versus the consensus of $4.90.

For earnings history and earnings-related data on Mylan (MYL) click here.

Earnings Guidance

Mylan (MYL) Miss Overshadowed by Mediocre Deal - Guggenheim February 11, 2016 8:07 AM RBC Capital Views Mylan's (MYL) Meda Purchase as Desperate - PT to $58 February 11, 2016 8:05 AM Mylan Full Year Adjusted Diluted EPS Up 21% to $4.30February 10, 2016 4:11 PM Mylan (MYL) Enters Agreement to Acquire Meda in ~$9.9B DealFebruary 10, 2016 4:03 PM Mylan to Acquire MedaFebruary 10, 2016 4:02 PM Mylan (MYL) to Announce Takeover of Meda - FTFebruary 10, 2016 3:47 PM Form 4 Mylan N.V. For: Feb 05 Filed by: Campbell PaulFebruary 9, 2016 7:00 PM